BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb debt to equity ratio

Bristol-Myers Squibb's debt to equity ratio is 1.91: total debt of 44.81B USD against shareholders' equity of 23.40B USD.

Today
1.91
Average, 5 years
2.10
Low, 5 years
1.23
High, 5 years
3.48

Debt to equity = total debt ÷ shareholders' equity = 44.81B ÷ 23.40B = 1.91

Debt to equity
Total debt
Shareholders' equity

Total debt over shareholders' equity at each quarter end.

Debt to equity by year and by quarter

Fiscal yearPeriod endingDebt to equityTotal debtShareholders' equity
Today1.9144.81B23.40B
FY202531 Dec 20252.5547.14B18.47B
FY202431 Dec 20243.1351.20B16.34B
FY202331 Dec 20231.4141.46B29.43B
FY202231 Dec 20221.3140.72B31.06B
FY202131 Dec 20211.2745.60B35.95B
FY202031 Dec 20201.3751.67B37.82B
FY201931 Dec 20190.9247.54B51.60B
FY201831 Dec 20180.527.35B14.03B
FY201731 Dec 20170.687.96B11.74B
FY201631 Dec 20160.416.71B16.18B
FY201531 Dec 20150.476.69B14.27B
FY201431 Dec 20140.537.83B14.85B
FY201331 Dec 20130.558.34B15.15B
FY201231 Dec 20120.547.39B13.62B
FY201131 Dec 20110.345.49B15.96B
FY201031 Dec 20100.355.45B15.71B
FY200931 Dec 20090.436.36B14.84B
FY200831 Dec 20080.556.74B12.24B
FY200731 Dec 20070.596.27B10.56B
FY200631 Dec 20060.747.44B9.99B
FY200531 Dec 20050.778.60B11.21B
FY200431 Dec 20041.0110.35B10.20B
FY200331 Dec 20030.898.75B9.79B
FY200231 Dec 20020.877.64B8.76B
FY200131 Dec 20010.716.41B9.08B
FY200031 Dec 20000.161.50B9.18B
FY199931 Dec 19990.211.77B8.65B
FY199831 Dec 19980.241.85B7.58B
FY199731 Dec 19970.251.82B7.22B
FY199631 Dec 19960.231.48B6.57B
FY199531 Dec 19950.211.21B5.82B
FY199431 Dec 19940.241.37B5.70B
FY199331 Dec 19930.13765.00M5.94B
FY199231 Dec 19920.09551.00M6.02B
FY199131 Dec 19910.12688.00M5.80B
FY199031 Dec 19900.12628.00M5.42B
FY198931 Dec 19890.10518.00M5.08B
FY198831 Dec 19880.19963.00M4.95B
FY198731 Dec 19870.15694.00M4.76B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios

Common questions about Bristol-Myers Squibb's debt to equity

Source: Financial Modeling PrepVerified against SEC filings